IQVIA Holdings Inc. operates primarily through two main segments: Research & Development Solutions and Commercial Solutions. The Research & Development segment functions as a global contract research organization (CRO), managing all phases of clinical trials, patient recruitment, and regulatory affairs for biopharmaceutical clients. The Commercial Solutions segment provides cloud-based software, real-world evidence analytics, and strategic consulting powered by one of the world's largest healthcare data networks. Headquartered in Durham, North Carolina, the company serves clients across the Americas, Europe, Africa, and the Asia-Pacific region. IQVIA's competitive advantage lies in its ability to integrate clinical trial execution with advanced data analytics, enabling faster and more efficient drug development and market access.
